Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piotr Eder

Showing results (91-100 of 114) with videos related to

Pageof 12
Sort By:
Przeglad Gastroenterologiczny|April 3, 2023
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in GastroenterologyPiotr Eder, Michał Łodyga, Magdalena Gawron-Kiszka, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|April 1, 2019
Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseasesAleksandra Szymczak-Tomczak, Iwona Krela-Kaźmierczak, Marta Kaczmarek-Ryś, et al.
International Journal of Environmental Research and Public Health|July 2, 2020
Nanotoxicology and Nanosafety: Safety-By-Design and Testing at a GlanceAleksandra Zielińska, Beatriz Costa, Maria V Ferreira, et al.
Journal of Clinical Medicine|August 28, 2019
<i>ESR1</i> Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's DiseaseIwona Krela-Kaźmierczak, Marzena Skrzypczak-Zielińska, Marta Kaczmarek-Ryś, et al.
Journal of Crohn'S & Colitis|December 1, 2022
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case seriesHussein Mahajna, Bram Verstockt, Daniel Bergemalm, et al.
Frontiers in Pharmacology|September 14, 2020
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients?Michal Walczak, Liliana Lykowska-Szuber, Marianna Plucinska, et al.
Journal of Crohn'S & Colitis|December 21, 2022
Multidisciplinary Perinatal Care in IBDLihi Godny, Vaios Svolos, Astrid-Jane Williams, et al.
Journal of Crohn'S & Colitis|July 18, 2021
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case SeriesAhmad Albshesh, Piotr Eder, Davide Giuseppe Ribaldone, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|May 11, 2023
Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational studyEdyta Zagórowicz, Halina Cichoż-Lach, Maria Kopertowska-Majchrzak, et al.
Therapeutic Advances in Gastroenterology|November 22, 2024
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II)Ariel Liebert, Maria Kłopocka, Agata Michalak, et al.
Pageof 12

Showing results (91-100 of 114) with videos related to

Sort By:
Pageof 12
Przeglad Gastroenterologiczny|April 3, 2023
Guidelines for the management of ulcerative colitis. Recommendations of the Polish Society of Gastroenterology and the Polish National Consultant in GastroenterologyPiotr Eder, Michał Łodyga, Magdalena Gawron-Kiszka, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|April 1, 2019
Vitamin D receptor (VDR) TaqI polymorphism, vitamin D and bone mineral density in patients with inflammatory bowel diseasesAleksandra Szymczak-Tomczak, Iwona Krela-Kaźmierczak, Marta Kaczmarek-Ryś, et al.
International Journal of Environmental Research and Public Health|July 2, 2020
Nanotoxicology and Nanosafety: Safety-By-Design and Testing at a GlanceAleksandra Zielińska, Beatriz Costa, Maria V Ferreira, et al.
Journal of Clinical Medicine|August 28, 2019
<i>ESR1</i> Gene Variants Are Predictive of Osteoporosis in Female Patients with Crohn's DiseaseIwona Krela-Kaźmierczak, Marzena Skrzypczak-Zielińska, Marta Kaczmarek-Ryś, et al.
Journal of Crohn'S & Colitis|December 1, 2022
Idiopathic Thrombocytopaenic Purpura associated with Inflammatory Bowel Disease: a multicentre ECCO CONFER case seriesHussein Mahajna, Bram Verstockt, Daniel Bergemalm, et al.
Frontiers in Pharmacology|September 14, 2020
Is Polymorphism in the Apoptosis and Inflammatory Pathway Genes Associated With a Primary Response to Anti-TNF Therapy in Crohn's Disease Patients?Michal Walczak, Liliana Lykowska-Szuber, Marianna Plucinska, et al.
Journal of Crohn'S & Colitis|December 21, 2022
Multidisciplinary Perinatal Care in IBDLihi Godny, Vaios Svolos, Astrid-Jane Williams, et al.
Journal of Crohn'S & Colitis|July 18, 2021
Primary Hypogammaglobulinaemia with Inflammatory Bowel Disease-Like Features: An ECCO CONFER Multicentre Case SeriesAhmad Albshesh, Piotr Eder, Davide Giuseppe Ribaldone, et al.
Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University|May 11, 2023
Real-world effectiveness and safety of vedolizumab induction therapy for ulcerative colitis: A prospective nationwide Polish observational studyEdyta Zagórowicz, Halina Cichoż-Lach, Maria Kopertowska-Majchrzak, et al.
Therapeutic Advances in Gastroenterology|November 22, 2024
Effectiveness and safety outcomes after long-term (54 weeks) vedolizumab therapy for Crohn's disease: a prospective, real-world observational study including patient-reported outcomes (POLONEZ II)Ariel Liebert, Maria Kłopocka, Agata Michalak, et al.
Pageof 12